IL-9 signaling as key driver of chronic inflammation in mucosal immunity

Strober, 1982, The regulation of mucosal immune system, J. Allergy Clin. Immunol., 70, 225, 10.1016/0091-6749(82)90057-4 Strober, 2007, The fundamental basis of inflammatory bowel disease, J. Clin. Invest., 117, 514, 10.1172/JCI30587 Brandtzaeg, 2009, Mucosal immunity: induction, dissemination, and effector functions, Scand. J. Immunol., 70, 505, 10.1111/j.1365-3083.2009.02319.x Neurath, 2002, The role of Th1/Th2 polarization in mucosal immunity, Nat. Med., 8, 567, 10.1038/nm0602-567 Uyttenhove, 1988, Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity, Proc. Natl. Acad. Sci. U. S. A., 85, 6934, 10.1073/pnas.85.18.6934 Schmitt, 1989, TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor, Eur. J. Immunol., 19, 2167, 10.1002/eji.1830191130 Simpson, 1989, Complete amino acid sequence of a new murine T-cell growth factor P40, Eur. J. Biochem., 183, 715, 10.1111/j.1432-1033.1989.tb21103.x Van Snick, 1989, Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40), J. Exp. Med., 169, 363, 10.1084/jem.169.1.363 Renauld, 1990, Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene, J. Immunol., 144, 4235, 10.4049/jimmunol.144.11.4235 Yang, 1989, Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40, Blood, 74, 1880, 10.1182/blood.V74.6.1880.1880 Renauld, 1992, Expression cloning of the murine and human interleukin 9 receptor cDNAs, Proc. Natl. Acad. Sci. U. S. A., 89, 5690, 10.1073/pnas.89.12.5690 Veldhoen, 2008, Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset, Nat. Immunol., 9, 1341, 10.1038/ni.1659 Elyaman, 2009, IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells, Proc. Natl. Acad. Sci. U. S. A., 106, 12885, 10.1073/pnas.0812530106 Druez, 1990, Functional and biochemical characterization of mouse P40/IL-9 receptors, J. Immunol., 145, 2494, 10.4049/jimmunol.145.8.2494 Hultner, 2000, In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9, J. Immunol., 164, 5556, 10.4049/jimmunol.164.11.5556 Mohamadzadeh, 1996, Expression of the common cytokine receptor gamma chain by murine dendritic cells including epidermal Langerhans cells, Eur. J. Immunol., 26, 156, 10.1002/eji.1830260124 Noelle, 2010, Cellular sources and immune functions of interleukin-9, Nat. Rev. Immunol., 10, 683, 10.1038/nri2848 Schmitt, 1994, IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma, J. Immunol., 153, 3989, 10.4049/jimmunol.153.9.3989 Dardalhon, 2008, IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells, Nat. Immunol., 9, 1347, 10.1038/ni.1677 Yao, 2013, Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP, Immunity, 38, 360, 10.1016/j.immuni.2013.01.007 Kaplan, 2013, Th9 cells: differentiation and disease, Immunol. Rev., 252, 104, 10.1111/imr.12028 Kaplan, 2015, The development and in vivo function of T helper 9 cells, Nat. Rev. Immunol., 15, 295, 10.1038/nri3824 Zhu, 1996, Multiple transcription factors are required for activation of human interleukin 9 gene in T cells, J. Biol. Chem., 271, 15815, 10.1074/jbc.271.26.15815 Jash, 2012, Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-kappaB (NF-kappaB)-mediated interleukin-9 (IL-9) transactivation, J. Biol. Chem., 287, 15445, 10.1074/jbc.M112.340356 Xiao, 2012, OX40 signaling favors the induction of T(H) 9 cells and airway inflammation, Nat. Immunol., 13, 981, 10.1038/ni.2390 Murugaiyan, 2012, IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27, J. Immunol., 189, 5277, 10.4049/jimmunol.1200808 Bassil, 2014, BCL6 controls Th9 cell development by repressing Il9 transcription, J. Immunol., 193, 198, 10.4049/jimmunol.1303184 Liao, 2014, Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression, Proc. Natl. Acad. Sci. U. S. A., 111, 3508, 10.1073/pnas.1301138111 Goswami, 2012, STAT6-dependent regulation of Th9 development, J. Immunol., 188, 968, 10.4049/jimmunol.1102840 Jabeen, 2013, Th9 cell development requires a BATF-regulated transcriptional network, J. Clin. Invest., 123, 4641, 10.1172/JCI69489 Staudt, 2010, Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells, Immunity, 33, 192, 10.1016/j.immuni.2010.07.014 Chang, 2010, The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation, Nat. Immunol., 11, 527, 10.1038/ni.1867 Goswami, 2012, Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells, J. Immunol., 189, 3026, 10.4049/jimmunol.1201496 Tamiya, 2013, Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction, J. Immunol., 191, 2360, 10.4049/jimmunol.1301276 Wang, 2013, Cutting edge: Smad2 and Smad4 regulate TGF-beta-mediated Il9 gene expression via EZH2 displacement, J. Immunol., 191, 4908, 10.4049/jimmunol.1300433 Elyaman, 2012, Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells, Immunity, 36, 623, 10.1016/j.immuni.2012.01.020 Stassen, 2000, Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1, J. Immunol., 164, 5549, 10.4049/jimmunol.164.11.5549 Shimbara, 2000, IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma, J. Allergy Clin. Immunol., 105, 108, 10.1016/S0091-6749(00)90185-4 Abdelilah, 2001, Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release, J. Immunol., 166, 2768, 10.4049/jimmunol.166.4.2768 Barlow, 2014, Type-2 innate lymphoid cells in human allergic disease, Curr. Opin. Allergy Clin. Immunol., 14, 397, 10.1097/ACI.0000000000000090 Holgate, 2012, Innate and adaptive immune responses in asthma, Nat. Med., 18, 673, 10.1038/nm.2731 Doull, 1996, Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness, Am. J. Respir. Crit. Care Med., 153, 1280, 10.1164/ajrccm.153.4.8616554 Sordillo, 2015, Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity, J. Allergy Clin. Immunol., 136, 885, 10.1016/j.jaci.2015.02.035 Kauppi, 2000, The IL9 R region contribution in asthma is supported by genetic association in an isolated population, Eur. J. Hum. Genet., 8, 788, 10.1038/sj.ejhg.5200541 Erpenbeck, 2003, Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes, J. Allergy Clin. Immunol., 111, 1319, 10.1067/mai.2003.1485 Gounni, 2000, IL-9 expression by human eosinophils: regulation by IL-1 beta and TNF-alpha, J. Allergy Clin. Immunol., 106, 460, 10.1067/mai.2000.109172 Hoppenot, 2015, p-STAT6, PU.1, and NF-kappaB are involved in allergen-induced late-phase airway inflammation in asthma patients, BMC Pulm. Med., 15, 122, 10.1186/s12890-015-0119-7 Hoppenot, 2015, Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients, Medicina (Kaunas), 51, 10, 10.1016/j.medici.2015.01.001 Nouri-Aria, 2005, IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy, J. Allergy Clin. Immunol., 116, 73, 10.1016/j.jaci.2005.03.011 Bhathena, 2000, Interleukin-9 receptor expression in asthmatic airways In vivo, Lung, 178, 149, 10.1007/s004080000018 Toda, 2002, A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma, J. Allergy Clin. Immunol., 109, 246, 10.1067/mai.2002.121555 Kearley, 2011, IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways, Am. J. Respir. Crit. Care Med., 183, 865, 10.1164/rccm.200909-1462OC Vermeer, 2003, Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia, Am. J. Respir. Cell Mol. Biol., 28, 286, 10.1165/rcmb.4887 Baraldo, 2003, Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK, Am. J. Physiol. Lung Cell. Mol. Physiol., 284, L1093, 10.1152/ajplung.00300.2002 Gounni, 2004, IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells, J. Immunol., 173, 2771, 10.4049/jimmunol.173.4.2771 Levitt, 1999, IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders, J. Allergy Clin. Immunol., 103, S485, 10.1016/S0091-6749(99)70165-X Sehra, 2015, TH9 cells are required for tissue mast cell accumulation during allergic inflammation, J. Allergy Clin. Immunol., 136, 433, 10.1016/j.jaci.2015.01.021 Visekruna, 2013, Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation, Eur. J. Immunol., 43, 606, 10.1002/eji.201242825 Ubel, 2014, The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma, J. Allergy Clin. Immunol., 133, 198, 10.1016/j.jaci.2013.09.049 Claudio, 2015, Cutting Edge IL-25 Targets Dendritic Cells To Attract IL-9-Producing T Cells in Acute Allergic Lung Inflammation, J. Immunol., 195, 3525, 10.4049/jimmunol.1500436 Dong, 1999, IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice, Eur. J. Immunol., 29, 2130, 10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S Temann, 2002, Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology, J. Clin. Invest., 109, 29, 10.1172/JCI0213696 McLane, 1998, Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice, Am. J. Respir. Cell Mol. Biol., 19, 713, 10.1165/ajrcmb.19.5.3457 Louahed, 2000, Interleukin-9 upregulates mucus expression in the airways, Am. J. Respir. Cell Mol. Biol., 22, 649, 10.1165/ajrcmb.22.6.3927 Steenwinckel, 2007, IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells, J. Immunol., 178, 3244, 10.4049/jimmunol.178.5.3244 Longphre, 1999, Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells, J. Clin. Invest., 104, 1375, 10.1172/JCI6097 van den Brule, 2007, Profibrotic effect of IL-9 overexpression in a model of airway remodeling, Am. J. Respir. Cell Mol. Biol., 37, 202, 10.1165/rcmb.2006-0397OC Cheng, 2002, Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model, Am. J. Respir. Crit. Care Med., 166, 409, 10.1164/rccm.2105079 Ubel, 2014, Role of Tyk-2 in Th9 and Th17 cells in allergic asthma, Sci. Rep., 4, 5865, 10.1038/srep05865 McNamara, 2004, Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis, Lancet, 363, 1031, 10.1016/S0140-6736(04)15838-8 Oh, 2013, A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma, Respir. Res., 14, 93, 10.1186/1465-9921-14-93 Steenwinckel, 2009, IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa, J. Immunol., 182, 4737, 10.4049/jimmunol.0801941 Brough, 2014, IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy, J. Allergy Clin. Immunol., 134, 1329, 10.1016/j.jaci.2014.06.032 Chen, 2015, Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy, Immunity, 43, 788, 10.1016/j.immuni.2015.08.020 Barrett, 2015, Licensed to Ill: IL-9 generation in immature mast cells permits food-elicited anaphylaxis, Immunity, 43, 626, 10.1016/j.immuni.2015.09.011 Liu, 2014, IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis, J. Invest. Dermatol., 134, 1903, 10.1038/jid.2014.61 Peyrin-Biroulet, 2010, The natural history of adult Crohn's disease in population-based cohorts, Am. J. Gastroenterol., 105, 289, 10.1038/ajg.2009.579 Peyrin-Biroulet, 2011, Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts, Inflamm. Bowel Dis., 17, 471, 10.1002/ibd.21417 Neurath, 2012, Mucosal healing in inflammatory bowel diseases: a systematic review, Gut, 61, 1619, 10.1136/gutjnl-2012-302830 Neurath, 2014, Cytokines in inflammatory bowel disease, Nat. Rev. Immunol., 14, 329, 10.1038/nri3661 Monteleone, 2011, Th17-related cytokines: new players in the control of chronic intestinal inflammation, BMC Med., 9, 122, 10.1186/1741-7015-9-122 Gerlach, 2014, TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells, Nat. Immunol., 15, 676, 10.1038/ni.2920 Nalleweg, 2014, IL-9 and its receptor are predominantly involved in the pathogenesis of UC, Gut Defendenti, 2015, Significance of serum Il-9 levels in inflammatory bowel disease, Int. J. Immunopathol. Pharmacol., 28, 569, 10.1177/0394632015600535 Gerlach, 2015, IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis, Tissue Barriers, 3, e983777, 10.4161/21688370.2014.983777 Kim, 2013, IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner, Mucosal Immunol., 6, 347, 10.1038/mi.2012.77 Yuan, 2015, IL-9 antibody injection suppresses the inflammation in colitis mice, Biochem. Biophys. Res. Commun., 468, 921, 10.1016/j.bbrc.2015.11.057 Sandborn, 2012, Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis, N. Engl. J. Med., 367, 616, 10.1056/NEJMoa1112168 Sandborn, 2014, A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn’s disease, Clin. Gastroenterol. Hepatol., 10.1016/j.cgh.2014.01.029 Ruocco, 2015, T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis, Clin Sci (Lond.), 129, 291, 10.1042/CS20140608 Nowak, 2009, IL-9 as a mediator of Th17-driven inflammatory disease, J. Exp. Med., 206, 1653, 10.1084/jem.20090246 Leng, 2012, Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus, Am. J. Clin. Exp. Immunol., 1, 28 Neurath, 2014, Cytokines in inflammatory bowel disease, Nat. Rev. Immunol., 14, 329, 10.1038/nri3661